Health
Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study – Yahoo India News
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the…
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.
The UK findings are said to be based on…
-
General23 hours agoOf saints and sinners | The Spectator Australia
-
General23 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News13 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General23 hours agoWhy the nation needs the Nationals to ditch Net Zero